Parth Mehrotra - 27 Apr 2023 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Signature
/s/ Thomas Bartrum, as attorney-in-fact
Issuer symbol
PRVA
Transactions as of
27 Apr 2023
Net transactions value
-$28,652
Form type
4
Filing time
01 May 2023, 18:06:20 UTC
Previous filing
14 Apr 2023
Next filing
03 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, $0.01 par value per share Options Exercise $2,204 +1,102 +1.1% $2.00* 98,493 27 Apr 2023 Direct
transaction PRVA Common Stock, $0.01 par value per share Sale $30,856 -1,102 -1.1% $28.00 97,391 27 Apr 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVA Stock Option (Right to Purchase) Options Exercise $0 -1,102 -2.3% $0.000000 46,438 27 Apr 2023 Common Stock 1,102 $2.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022.
F2 All stock options are fully vested and exercisable.